The Trump transition team has begun conferring with the Department of Health and Human Services. So far, though, it’s steered clear of the Food and Drug Administration.
Members of Trump’s health policy landing team held two introductory sessions on Friday with non-political staff at HHS, according to sources familiar with the meetings.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
